Combination therapies with thiazolidinediones are associated with a lower risk of acute exacerbations in new-onset COPD patients with advanced diabetic mellitus: a cohort-based case–control study

Combination therapies with thiazolidinediones are associated with a lower risk of acute exacerbations in new-onset COPD patients with advanced diabetic mellitus: a cohort-based case–control study

Abstract Background The effects of oral antihyperglycaemic drugs (OADs) for type 2 diabetes mellitus (T2DM) on the outcomes of co-existing chronic obstructive pulmonary disease (COPD) patients are not well studied. We examined the association of combinational OADs and the risk of acute exacerbations...

Full description

Bibliographic Details
Main Authors: Kuan-Yuan Chen, Sheng-Ming Wu, Chien-Hua Tseng, Kang-Yun Lee, Yu-Huei Lin, Hung-Yi Liu, Li-Nien Chien
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Pulmonary Medicine
Subjects:
Oral antihyperglycaemic drugs (OADs)
Thiazolidinediones (TZDs)
Type 2 diabetes mellitus (T2DM)
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Online Access:https://doi.org/10.1186/s12890-021-01505-7

Internet

https://doi.org/10.1186/s12890-021-01505-7

Similar Items